Dr. Carthon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1365B Clifton Rd NE
Ste B4300
Atlanta, GA 30322Phone+1 404-778-0605
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
- Massachusetts General HospitalResidency, Internal Medicine, 2005 - 2008
- Harvard Medical SchoolClass of 2005
Certifications & Licensure
- GA State Medical License 2011 - 2025
- TX State Medical License 2008 - 2013
- MA State Medical License 2007 - 2010
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Axitinib and Temsirolimus in Solid Tumors Start of enrollment: 2011 Oct 01
- Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumors Start of enrollment: 2014 Aug 01
Publications & Presentations
PubMed
- 10 citationsClinical Outcomes and Racial Disparities in Metastatic Hormone-Sensitive Prostate Cancer in the Era of Novel Treatment Options.Katherine Emilie Rhoades Smith, Jacqueline T. Brown, Limeng Wan, Yuan Liu, Greta Russler
The Oncologist. 2021-06-29 - 27 citationsTargeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter study.Paolo Andrea Zucali, Chia-Chi Lin, Bradley C Carthon, Todd M Bauer, Marcello Tucci
Journal for Immunotherapy of Cancer. 2022-01-01 - 43 citationsAdiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trialsDylan J. Martini, Meredith R Kline, Yuan Liu, Julie M. Shabto, Milton Williams
Cancer. 2020-02-01
Journal Articles
- The Addition of Chemotherapy in the Definitive Management of High Risk Prostate CancerBradley C Carthon, Mehmet A Bilen, Omer Kucuk, Urologic Oncology
Authored Content
- The Addition of Chemotherapy in the Definitive Management of High Risk Prostate CancerOctober 2018
Press Mentions
- Atlanta Hawks Launch Third Annual ‘Black History Month Assist Challenge’ to Support the Prostate Cancer FoundationFebruary 4th, 2021
- Atlanta Hawks Launch ‘Black History Month Assist Challenge’ for Prostate Cancer AwarenessJanuary 28th, 2021
- Some Cancer Patients Can Find It Hard to Tell Family and FriendsMarch 29th, 2024
Grant Support
- Minority Predoctoral Fellowship ProgramNational Cancer Institute1999–2003
- Minority Predoctoral Fellowship ProgramNational Heart, Lung, And Blood Institute1998
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: